Targeted delivery of siRNA into breast cancer cells via phage fusion proteins

Molecular Pharmaceutics

Volumn 10, Issue 2, 2013, Pages 551-559

  Petrenko, Valery A ^a   Bedi, Deepa ^a   Gillespie, James W ^c   Petrenko, Vasily A ^a   Ebner, Andreas ^b   Leitner, Michael ^b   Hinterdorfer, Peter ^b  

^a AUBURN UNIVERSITY   (United States)

^b JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^c NONE

Author keywords

cancer targeting peptides; landscape phage; nanoparticles; siRNA; tumor

Indexed keywords

COAT PROTEIN; LIGAND; NANOPARTICLE; NUCLEASE; SMALL INTERFERING RNA; VIRUS FUSION PROTEIN;

ARTICLE; ATOMIC FORCE MICROSCOPY; BACTERIOPHAGE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; DRUG STABILITY; DRUG TARGETING; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; HUMAN; HUMAN CELL; MOLECULAR LIBRARY; PRIORITY JOURNAL; PROTEIN ISOLATION; TARGET CELL; VIRUS CHARACTERIZATION;

EID: 84873387895     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3006006     Document Type: Article

References (44)

1. Santiago, F.; Khachigian, L. Nucleic acid based strategies as potential therapeutic tools: mechanistic considerations and implications to restenosis J. Mol. Med. 2001, 79 (12) 695-706 (Pubitemid 34025118)
2. Patil, S. D.; Rhodes, D. G.; Burgess, D. J. DNA-based therapeutics and DNA delivery systems: a comprehensive review AAPS J. 2005, 7 (1) E61-E77 (Pubitemid 41554297)
3. Pouton, C. W.; Seymour, L. W. Key issues in non-viral gene delivery Adv. Drug Delivery Rev. 1998, 34 (1) 3-19 (Pubitemid 28464475)
4. Pouton, C. W.; Seymour, L. W. Key issues in non-viral gene delivery Adv. Drug Delivery Rev. 2001, 46 (1-3) 187-203
5. Laufer, S. D.; Restle, T. Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems Curr. Pharm. Des. 2008, 14 (34) 3637-55
6. Krumpe, L. R.; Mori, T. The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs Int. J. Pept. Res. Ther. 2006, 12 (1) 79-91
7. Smith, G. P.; Petrenko, V. A. Phage Display Chem. Rev. 1997, 97 (2) 391-410 (Pubitemid 127659250)
8. Rasmussen, U. B.; Schreiber, V.; Schultz, H.; Mischler, F.; Schughart, K. Tumor cell-targeting by phage-displayed peptides Cancer Gene Ther. 2002, 9 (7) 606-612 (Pubitemid 34734425)
9. Brown, K. C. Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications Curr. Pharm. Des. 2010, 16 (9) 1040-54
10. Petrenko, V. A.; Smith, G. P.; Gong, X.; Quinn, T. A library of organic landscapes on filamentous phage Protein Eng. 1996, 9 (9) 797-801 (Pubitemid 26308528)
11. Jayanna, P. K.; Torchilin, V. P.; Petrenko, V. A. Liposomes targeted by fusion phage proteins Nanomedicine 2009, 5 (1) 83-89
12. Samoylova, T. I.; Petrenko, V. A.; Morrison, N. E.; Globa, L. P.; Baker, H. J.; Cox, N. R. Phage probes for malignant glial cells Mol. Cancer Ther. 2003, 2 (11) 1129-1137
13. Romanov, V. I.; Durand, D. B.; Petrenko, V. A. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion Prostate 2001, 47 (4) 239-251 (Pubitemid 32521743)
14. Fagbohun, O. A.; Bedi, D.; Grabchenko, N. I.; Deinnocentes, P. A.; Bird, R. C.; Petrenko, V. A. Landscape phages and their fusion proteins targeted to breast cancer cells Protein Eng. Des. Sel. 2012, 25 (6) 271-283
15. Jayanna, P. K.; Bedi, D.; Gillespie, J. W.; DeInnocentes, P.; Wang, T.; Torchilin, V. P.; Bird, R. C.; Petrenko, V. A. Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency Nanomedicine 2010, 6 (4) 538-546
16. Wang, T.; D'Souza, G. G.; Bedi, D.; Fagbohun, O. A.; Potturi, L. P.; Papahadjopoulos-Sternberg, B.; Petrenko, V. A.; Torchilin, V. P. Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein Nanomedicine (London) 2010, 5 (4) 563-574
17. Wang, T.; Petrenko, V. A.; Torchilin, V. P. Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity Mol. Pharmaceutics 2010, 7 (4) 1007-1014
18. Bedi, D.; Musacchio, T.; Fagbohun, O. A.; Gillespie, J. W.; Deinnocentes, P.; Bird, R. C.; Bookbinder, L.; Torchilin, V. P.; Petrenko, V. A. Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes Nanomedicine 2011, 7 (3) 315-323
19. Petrenko, V. A.; Smith, G. P. Phages from landscape libraries as substitute antibodies Protein Eng. 2000, 13 (8) 589-592
20. Kuzmicheva, G. A.; Jayanna, P. K.; Sorokulova, I. B.; Petrenko, V. A. Diversity and censoring of landscape phage libraries Protein Eng. Des. Sel. 2009, 22 (1) 9-18
21. Brigati, J. R.; Samoylova, T. I.; Jayanna, P. K.; Petrenko, V. A. Phage display for generating peptide reagents. Curr. Protoc. Protein Sci. 2008, Chapter 18, Unit 18.9.
22. Spruijt, R. B.; Wolfs, C. J.; Hemminga, M. A. Aggregation-related conformational change of the membrane-associated coat protein of bacteriophage M13 Biochemistry 1989, 28 (23) 9158-9165 (Pubitemid 19283485)
23. Ebner, A.; Hinterdorfer, P.; Gruber, H. J. Comparison of different aminofunctionalization strategies for attachment of single antibodies to AFM cantilevers Ultramicroscopy 2007, 107 (10-11) 922-927 (Pubitemid 47095101)
24. Knecht, D. A.; Loomis, W. F. Antisense RNA inactivation of myosin heavy chain gene expression in Dictyostelium discoideum Science 1987, 236 (4805) 1081-1086 (Pubitemid 17113249)
25. Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 2001, 411 (6836) 494-498 (Pubitemid 32494397)
26. Hu-Lieskovan, S.; Heidel, J. D.; Bartlett, D. W.; Davis, M. E.; Triche, T. J. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma Cancer Res. 2005, 65 (19) 8984-8992 (Pubitemid 41377390)
27. Khaled, A.; Guo, S.; Li, F.; Guo, P. Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology Nano Lett 2005, 5 (9) 1797-1808 (Pubitemid 41396168)
28. Tomalia, D. A.; Reyna, L. A.; Svenson, S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging Biochem. Soc. Trans. 2007, 35 (Part 1) 61-67
29. Halder, J.; Kamat, A. A.; Landen, C. N., Jr.; Han, L. Y.; Lutgendorf, S. K.; Lin, Y. G.; Merritt, W. M.; Jennings, N. B.; Chavez-Reyes, A.; Coleman, R. L.; Gershenson, D. M.; Schmandt, R.; Cole, S. W.; Lopez-Berestein, G.; Sood, A. K. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy Clin. Cancer Res. 2006, 12 (16) 4916-4924 (Pubitemid 44338579)
30. Guo, S.; Huang, F.; Guo, P. Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells Gene Ther. 2006, 13 (10) 814-820
31. Oishi, M.; Nagasaki, Y.; Itaka, K.; Nishiyama, N.; Kataoka, K. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells J. Am. Chem. Soc. 2005, 127 (6) 1624-1625 (Pubitemid 40229133)
32. Pirollo, K. F.; Chang, E. H. Targeted delivery of small interfering RNA: approaching effective cancer therapies Cancer Res. 2008, 68 (5) 1247-1250 (Pubitemid 351346828)
33. Zhang, H. M.; Su, Y.; Guo, S.; Yuan, J.; Lim, T.; Liu, J.; Guo, P.; Yang, D. Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs Antiviral Res. 2009, 83 (3) 307-316
34. Tan, W. B.; Jiang, S.; Zhang, Y. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference Biomaterials 2007, 28 (8) 1565-1571 (Pubitemid 46039833)
35. McNamara, J. O., 2nd; Andrechek, E. R.; Wang, Y.; Viles, K. D.; Rempel, R. E.; Gilboa, E.; Sullenger, B. A.; Giangrande, P. H. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras Nat. Biotechnol. 2006, 24 (8) 1005-1015 (Pubitemid 44215395)
36. Brigati, J. R.; Petrenko, V. A. Thermostability of landscape phage probes Anal. Bioanal. Chem. 2005, 382 (6) 1346-1350 (Pubitemid 41117843)
37. Jain, K. K. The role of nanobiotechnology in drug discovery Drug Discovery Today 2005, 10 (21) 1435-1442 (Pubitemid 41483872)
38. Li, W.; Szoka, F. C., Jr. Lipid-based nanoparticles for nucleic acid delivery Pharm. Res. 2007, 24 (3) 438-449 (Pubitemid 46295166)
39. Kim, S. H.; Jeong, J. H.; Lee, S. H.; Kim, S. W.; Park, T. G. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy J. Controlled Release 2006, 116 (2) 123-129 (Pubitemid 44854271)
40. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 2001, 53 (2) 283-318 (Pubitemid 32476118)
41. Webster, R. Filamentous Phage Biology. In Phage display: a laboratory manual; Barbas, C. F., III; Burton, D. R.; Scott, J. K.; Silverman, G. J. Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2001; pp 1.1-1.37.
42. Opella, S. J. The Roles of Structure, Dynamics and Assembly in the Display of Peptides on Filamentous Bacteriophage Phage. In Phage Nanobiotechnology; Petrenko, V. A.; Smith, G. P., Eds.; RSC: 2011; pp 12-32.
43. Lehninger Principles of Biochemistry, 4 th ed.; Nelson, D. L.; Cox, M., Eds.; W. H. Freeman and Company: New York; p 304.
44. Shu, D.; Shu, Y.; Haque, F.; Abdelmawla, S.; Guo, P. Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics Nat. Nanotechnol. 2011, 6, 658-667